Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hon Pui

Showing results (281-290 of 610) with videos related to

Pageof 61
Sort By:
Cancer Medicine|July 26, 2020
Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemiaSeth E Karol, Yilun Sun, Li Tang, et al.
Pediatric Blood & Cancer|September 16, 2004
Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemiaNobuko Hijiya, Monika L Metzger, Stan Pounds, et al.
Cancer|December 16, 2004
Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemiaGaston K Rivera, Yinmei Zhou, Michael L Hancock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2018
Peripheral Neuropathy, Sensory Processing, and Balance in Survivors of Acute Lymphoblastic LeukemiaMitra Varedi, Lu Lu, Carrie R Howell, et al.
Blood|August 10, 2006
Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemiaSima Jeha, Frederick Behm, Deqing Pei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemiaMary V Relling, Wenjian Yang, Soma Das, et al.
Blood|December 15, 2010
Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemiaJitesh D Kawedia, Sue C Kaste, Deqing Pei, et al.
Blood|January 18, 2003
Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatmentMary V Relling, James M Boyett, Javier G Blanco, et al.
Pediatric Blood & Cancer|February 15, 2011
Neuropathic pain during treatment for childhood acute lymphoblastic leukemiaDoralina L Anghelescu, Lane G Faughnan, Sima Jeha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Favorable impact of the t(9;11) in childhood acute myeloid leukemiaJeffrey E Rubnitz, Susana C Raimondi, Xin Tong, et al.
Pageof 61

Showing results (281-290 of 610) with videos related to

Sort By:
Pageof 61
Cancer Medicine|July 26, 2020
Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemiaSeth E Karol, Yilun Sun, Li Tang, et al.
Pediatric Blood & Cancer|September 16, 2004
Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemiaNobuko Hijiya, Monika L Metzger, Stan Pounds, et al.
Cancer|December 16, 2004
Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemiaGaston K Rivera, Yinmei Zhou, Michael L Hancock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2018
Peripheral Neuropathy, Sensory Processing, and Balance in Survivors of Acute Lymphoblastic LeukemiaMitra Varedi, Lu Lu, Carrie R Howell, et al.
Blood|August 10, 2006
Prognostic significance of CD20 expression in childhood B-cell precursor acute lymphoblastic leukemiaSima Jeha, Frederick Behm, Deqing Pei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemiaMary V Relling, Wenjian Yang, Soma Das, et al.
Blood|December 15, 2010
Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemiaJitesh D Kawedia, Sue C Kaste, Deqing Pei, et al.
Blood|January 18, 2003
Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatmentMary V Relling, James M Boyett, Javier G Blanco, et al.
Pediatric Blood & Cancer|February 15, 2011
Neuropathic pain during treatment for childhood acute lymphoblastic leukemiaDoralina L Anghelescu, Lane G Faughnan, Sima Jeha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Favorable impact of the t(9;11) in childhood acute myeloid leukemiaJeffrey E Rubnitz, Susana C Raimondi, Xin Tong, et al.
Pageof 61